AKT1 (AKT serine/threonine kinase 1)
|
Gene
|
Entrez ID
Entrez Gene ID - the GENE ID in NCBI Gene database.
|
207 |
Gene nameGene Name - the full gene name approved by the HGNC.
|
AKT serine/threonine kinase 1 |
Gene symbolGene Symbol - the official gene symbol approved by the HGNC, which is a short abbreviated form of the gene name.
|
AKT1 |
SynonymsGene synonyms aliases
|
AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA |
ChromosomeChromosome number
|
14 |
Chromosome locationChromosomal Location - indicates the cytogenetic location of the gene or region on the chromosome.
|
14q32.33 |
SummarySummary of gene provided in NCBI Entrez Gene.
|
This gene encodes one of the three members of the human AKT serine-threonine protein kinase family which are often referred to as protein kinase B alpha, beta, and gamma. These highly similar AKT proteins all have an N-terminal pleckstrin homology domain, a serine/threonine-specific kinase domain and a C-terminal regulatory domain. These proteins are phosphorylated by phosphoinositide 3-kinase (PI3K). AKT/PI3K forms a key component of many signalling pathways that involve the binding of membrane-bound ligands such as receptor tyrosine kinases, G-protein coupled receptors, and integrin-linked kinase. These AKT proteins therefore regulate a wide variety of cellular functions including cell proliferation, survival, metabolism, and angiogenesis in both normal and malignant cells. AKT proteins are recruited to the cell membrane by phosphatidylinositol 3,4,5-trisphosphate (PIP3) after phosphorylation of phosphatidylinositol 4,5-bisphosphate (PIP2) by PI3K. Subsequent phosphorylation of both threonine residue 308 and serine residue 473 is required for full activation of the AKT1 protein encoded by this gene. Phosphorylation of additional residues also occurs, for example, in response to insulin growth factor-1 and epidermal growth factor. Protein phosphatases act as negative regulators of AKT proteins by dephosphorylating AKT or PIP3. The PI3K/AKT signalling pathway is crucial for tumor cell survival. Survival factors can suppress apoptosis in a transcription-independent manner by activating AKT1 which then phosphorylates and inactivates components of the apoptotic machinery. AKT proteins also participate in the mammalian target of rapamycin (mTOR) signalling pathway which controls the assembly of the eukaryotic translation initiation factor 4F (eIF4E) complex and this pathway, in addition to responding to extracellular signals from growth factors and cytokines, is disregulated in many cancers. Mutations in this gene are associated with multiple types of cancer and excessive tissue growth including Proteus syndrome and Cowden syndrome 6, and breast, colorectal, and ovarian cancers. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2020] |
SNPsSNP information provided by dbSNP.
|
SNP ID |
Visualize variation |
Clinical significance |
Consequence |
rs121434592 |
C>T |
Pathogenic, likely-pathogenic, uncertain-significance |
Missense variant, coding sequence variant, non coding transcript variant |
rs368667384 |
G>A |
Conflicting-interpretations-of-pathogenicity |
Coding sequence variant, synonymous variant, non coding transcript variant |
rs397514644 |
G>A |
Pathogenic |
Coding sequence variant, missense variant, non coding transcript variant |
rs397514645 |
T>G |
Pathogenic |
Coding sequence variant, missense variant, non coding transcript variant |
rs1057518602 |
T>C |
Likely-pathogenic |
Non coding transcript variant, missense variant, coding sequence variant |
rs1057519804 |
G>T |
Likely-pathogenic |
Non coding transcript variant, missense variant, coding sequence variant |
rs1595251483 |
TC>CT |
Pathogenic |
Missense variant, non coding transcript variant, coding sequence variant |
|
miRNAmiRNA information provided by mirtarbase database.
|
miRTarBase ID |
miRNA |
Experiments |
Reference |
MIRT003984 |
hsa-miR-199a-3p |
Western blot |
18456660 |
MIRT004363 |
hsa-miR-125b-5p |
qRT-PCR, Western blot |
18649363 |
MIRT004701 |
hsa-miR-185-5p |
Flow, Immunoblot, Microarray, qRT-PCR |
19688090 |
MIRT005355 |
hsa-miR-149-3p |
Luciferase reporter assay, qRT-PCR, Western blot, Reporter assay;Western blot;qRT-PCR;Other |
20623644 |
MIRT005740 |
hsa-miR-451a |
qRT-PCR, Western blot |
20816946 |
MIRT007171 |
hsa-miR-302a-3p |
Luciferase reporter assay |
23185040 |
MIRT007172 |
hsa-miR-302b-3p |
Luciferase reporter assay |
23185040 |
MIRT007173 |
hsa-miR-302c-3p |
Luciferase reporter assay |
23185040 |
MIRT007174 |
hsa-miR-302d-3p |
Luciferase reporter assay |
23185040 |
MIRT007179 |
hsa-miR-143-3p |
Luciferase reporter assay, qRT-PCR, Western blot |
23104321 |
MIRT029530 |
hsa-miR-26b-5p |
Microarray |
19088304 |
MIRT041236 |
hsa-miR-193b-3p |
CLASH |
23622248 |
MIRT053334 |
hsa-miR-100-5p |
Luciferase reporter assay, Microarray, qRT-PCR, Western blot |
23724047 |
MIRT054156 |
hsa-miR-19a-3p |
qRT-PCR, Western blot |
25400827 |
MIRT054156 |
hsa-miR-19a-3p |
qRT-PCR, Western blot |
25914465 |
MIRT054875 |
hsa-miR-133b |
Luciferase reporter assay, qRT-PCR, Western blot |
25414595 |
MIRT277753 |
hsa-miR-542-3p |
Immunohistochemistry, Luciferase reporter assay, Western blot |
26286747 |
MIRT437386 |
hsa-miR-708-5p |
Flow, qRT-PCR, Western blot |
23754151 |
MIRT437912 |
hsa-miR-105-5p |
Luciferase reporter assay, Western blot |
25280563 |
MIRT438059 |
hsa-miR-27a-5p |
In situ hybridization, qRT-PCR |
23963114 |
MIRT442863 |
hsa-miR-192-3p |
PAR-CLIP |
22100165 |
MIRT442864 |
hsa-miR-155-5p |
PAR-CLIP |
22100165 |
MIRT442865 |
hsa-miR-496 |
PAR-CLIP |
22100165 |
MIRT442866 |
hsa-miR-4742-3p |
PAR-CLIP |
22100165 |
MIRT442867 |
hsa-miR-654-3p |
PAR-CLIP |
22100165 |
MIRT442868 |
hsa-miR-4757-3p |
PAR-CLIP |
22100165 |
MIRT442869 |
hsa-miR-365b-3p |
PAR-CLIP |
22100165 |
MIRT442870 |
hsa-miR-365a-3p |
PAR-CLIP |
22100165 |
MIRT543134 |
hsa-miR-3191-5p |
PAR-CLIP |
21572407 |
MIRT543135 |
hsa-miR-6873-3p |
PAR-CLIP |
21572407 |
MIRT543136 |
hsa-miR-6503-3p |
PAR-CLIP |
21572407 |
MIRT543137 |
hsa-miR-422a |
PAR-CLIP |
21572407 |
MIRT543138 |
hsa-miR-378i |
PAR-CLIP |
21572407 |
MIRT543139 |
hsa-miR-378h |
PAR-CLIP |
21572407 |
MIRT543140 |
hsa-miR-378f |
PAR-CLIP |
21572407 |
MIRT543141 |
hsa-miR-378e |
PAR-CLIP |
21572407 |
MIRT543142 |
hsa-miR-378d |
PAR-CLIP |
21572407 |
MIRT543143 |
hsa-miR-378c |
PAR-CLIP |
21572407 |
MIRT543144 |
hsa-miR-378b |
PAR-CLIP |
21572407 |
MIRT543145 |
hsa-miR-378a-3p |
PAR-CLIP |
21572407 |
MIRT543146 |
hsa-miR-4638-3p |
PAR-CLIP |
21572407 |
MIRT543147 |
hsa-miR-6824-3p |
PAR-CLIP |
21572407 |
MIRT543148 |
hsa-miR-6764-3p |
PAR-CLIP |
21572407 |
MIRT543149 |
hsa-miR-330-5p |
PAR-CLIP |
21572407 |
MIRT543150 |
hsa-miR-326 |
PAR-CLIP |
21572407 |
MIRT543151 |
hsa-miR-6817-3p |
PAR-CLIP |
21572407 |
MIRT543152 |
hsa-miR-518c-5p |
PAR-CLIP |
21572407 |
MIRT543153 |
hsa-miR-7110-3p |
PAR-CLIP |
21572407 |
MIRT543154 |
hsa-miR-6866-3p |
PAR-CLIP |
21572407 |
MIRT543155 |
hsa-miR-188-5p |
PAR-CLIP |
21572407 |
MIRT543156 |
hsa-miR-625-3p |
PAR-CLIP |
21572407 |
MIRT731064 |
hsa-miR-99a-5p |
Luciferase reporter assay |
25187230 |
MIRT731064 |
hsa-miR-99a-5p |
Luciferase reporter assay |
27158364 |
MIRT731198 |
hsa-miR-637 |
Immunohistochemistry, In situ hybridization, Western blot, Luciferase reporter assay |
25597410 |
MIRT731805 |
hsa-miR-495-3p |
Luciferase reporter assay, qRT-PCR, Western blot |
27323412 |
MIRT732839 |
hsa-miR-138-5p |
Immunohistochemistry, Luciferase reporter assay, Western blot |
28122142 |
MIRT733060 |
hsa-miR-184 |
Luciferase reporter assay |
27666871 |
MIRT733141 |
hsa-miR-196b-5p |
Flow, qRT-PCR, Western blot |
26998071 |
MIRT733152 |
hsa-miR-34a-5p |
Flow, qRT-PCR, Western blot |
27073535 |
MIRT733440 |
hsa-miR-206 |
qRT-PCR, Western blot |
28386239 |
MIRT733532 |
hsa-miR-409-3p |
Luciferase reporter assay, qRT-PCR, Western blot |
26631969 |
MIRT733740 |
hsa-miR-340-5p |
Western blot |
28057912 |
MIRT734052 |
hsa-miR-22-3p |
Luciferase reporter assay, Western blot |
26364720 |
MIRT734063 |
hsa-miR-192-5p |
Western blot |
26351877 |
MIRT734302 |
hsa-miR-125a-5p |
qRT-PCR, Western blot |
26622553 |
MIRT734751 |
hsa-miR-494-3p |
Immunofluorescence, Immunohistochemistry, qRT-PCR, Western blot |
25662849 |
MIRT734872 |
hsa-miR-4689 |
Luciferase reporter assay, qRT-PCR |
25756961 |
MIRT735321 |
hsa-miR-374b-5p |
Luciferase reporter assay, Microarray, qRT-PCR, Western blot |
26100275 |
MIRT735357 |
hsa-miR-185-3p |
Luciferase reporter assayMTT |
26617940 |
MIRT735362 |
hsa-miR-10b-5p |
qRT-PCR, Western blot |
27347488 |
MIRT735413 |
hsa-miR-382-3p |
qRT-PCR, Western blot, Immunostaining |
26636539 |
MIRT735543 |
hsa-miR-126-3p |
qRT-PCR, Western blot |
26659078 |
|
Transcription factors
|
|
Gene ontology (GO)Gene ontology information of associated ontologies with gene provided by GO database.
|
GO ID |
Ontology |
Definition |
Evidence |
Reference |
GO:0001649 |
Process |
Osteoblast differentiation |
IEA |
|
GO:0001893 |
Process |
Maternal placenta development |
IEA |
|
GO:0001934 |
Process |
Positive regulation of protein phosphorylation |
IDA |
19057511 |
GO:0001938 |
Process |
Positive regulation of endothelial cell proliferation |
IMP |
19850054 |
GO:0002042 |
Process |
Cell migration involved in sprouting angiogenesis |
IMP |
28341552 |
GO:0003376 |
Process |
Sphingosine-1-phosphate receptor signaling pathway |
IMP |
18558630 |
GO:0004672 |
Function |
Protein kinase activity |
TAS |
10570282 |
GO:0004674 |
Function |
Protein serine/threonine kinase activity |
EXP |
17030608 |
GO:0004674 |
Function |
Protein serine/threonine kinase activity |
IBA |
21873635 |
GO:0004674 |
Function |
Protein serine/threonine kinase activity |
IDA |
10102273, 10983986, 11994271, 16139227, 16540465, 19667065, 32322062 |
GO:0004674 |
Function |
Protein serine/threonine kinase activity |
NAS |
28386764 |
GO:0004674 |
Function |
Protein serine/threonine kinase activity |
TAS |
21432781, 21711983 |
GO:0004712 |
Function |
Protein serine/threonine/tyrosine kinase activity |
IDA |
22797923 |
GO:0005080 |
Function |
Protein kinase C binding |
IEA |
|
GO:0005515 |
Function |
Protein binding |
IPI |
10102273, 10983986, 11154276, 11438723, 11839802, 12176997, 12244133, 12791994, 16044149, 16139227, 16280327, 16282323, 16417524, 16525023, 16537421, 16792529, 17006541, 17577629, 17932490, 18191226, 18250332, 18292230, 18505846, 18562279, 18624398, 18650932, 18786403, 19162005, 191 |
GO:0005516 |
Function |
Calmodulin binding |
IDA |
29104511 |
GO:0005524 |
Function |
ATP binding |
IC |
11994271 |
GO:0005524 |
Function |
ATP binding |
IDA |
16540465 |
GO:0005547 |
Function |
Phosphatidylinositol-3,4,5-trisphosphate binding |
IDA |
19203586 |
GO:0005634 |
Component |
Nucleus |
IDA |
20333297 |
GO:0005634 |
Component |
Nucleus |
TAS |
21432781 |
GO:0005654 |
Component |
Nucleoplasm |
IDA |
|
GO:0005654 |
Component |
Nucleoplasm |
TAS |
|
GO:0005737 |
Component |
Cytoplasm |
IDA |
19203586, 25190803 |
GO:0005737 |
Component |
Cytoplasm |
ISS |
|
GO:0005737 |
Component |
Cytoplasm |
TAS |
21432781 |
GO:0005739 |
Component |
Mitochondrion |
IEA |
|
GO:0005819 |
Component |
Spindle |
IEA |
|
GO:0005829 |
Component |
Cytosol |
IDA |
21045808 |
GO:0005829 |
Component |
Cytosol |
TAS |
|
GO:0005886 |
Component |
Plasma membrane |
IDA |
14749367, 19203586, 20333297 |
GO:0005886 |
Component |
Plasma membrane |
TAS |
21432781 |
GO:0005911 |
Component |
Cell-cell junction |
IEA |
|
GO:0005978 |
Process |
Glycogen biosynthetic process |
IEA |
|
GO:0005979 |
Process |
Regulation of glycogen biosynthetic process |
IMP |
8940145 |
GO:0006006 |
Process |
Glucose metabolic process |
IEA |
|
GO:0006412 |
Process |
Translation |
IEA |
|
GO:0006417 |
Process |
Regulation of translation |
IEA |
|
GO:0006468 |
Process |
Protein phosphorylation |
IDA |
11994271, 14749367, 23431171 |
GO:0006469 |
Process |
Negative regulation of protein kinase activity |
IMP |
9373175 |
GO:0006469 |
Process |
Negative regulation of protein kinase activity |
ISS |
|
GO:0006606 |
Process |
Protein import into nucleus |
IMP |
16280327 |
GO:0006809 |
Process |
Nitric oxide biosynthetic process |
TAS |
10376602 |
GO:0006924 |
Process |
Activation-induced cell death of T cells |
IMP |
14749367 |
GO:0006954 |
Process |
Inflammatory response |
IEA |
|
GO:0006974 |
Process |
Cellular response to DNA damage stimulus |
IEA |
|
GO:0006979 |
Process |
Response to oxidative stress |
ISS |
|
GO:0007165 |
Process |
Signal transduction |
TAS |
21432781 |
GO:0007173 |
Process |
Epidermal growth factor receptor signaling pathway |
IDA |
20878056 |
GO:0007186 |
Process |
G protein-coupled receptor signaling pathway |
TAS |
10570282 |
GO:0007249 |
Process |
I-kappaB kinase/NF-kappaB signaling |
IMP |
26514923 |
GO:0007281 |
Process |
Germ cell development |
IEA |
|
GO:0007568 |
Process |
Aging |
IEA |
|
GO:0008283 |
Process |
Cell population proliferation |
TAS |
21432781 |
GO:0008284 |
Process |
Positive regulation of cell population proliferation |
IMP |
10983986 |
GO:0008286 |
Process |
Insulin receptor signaling pathway |
IMP |
8978681 |
GO:0008637 |
Process |
Apoptotic mitochondrial changes |
IEA |
|
GO:0008643 |
Process |
Carbohydrate transport |
IEA |
|
GO:0009408 |
Process |
Response to heat |
TAS |
10958679 |
GO:0010507 |
Process |
Negative regulation of autophagy |
IMP |
18387192 |
GO:0010595 |
Process |
Positive regulation of endothelial cell migration |
IMP |
18558630 |
GO:0010628 |
Process |
Positive regulation of gene expression |
IMP |
28341552 |
GO:0010628 |
Process |
Positive regulation of gene expression |
ISS |
18292230 |
GO:0010629 |
Process |
Negative regulation of gene expression |
IEA |
|
GO:0010748 |
Process |
Negative regulation of long-chain fatty acid import across plasma membrane |
IMP |
16814735 |
GO:0010761 |
Process |
Fibroblast migration |
NAS |
19126672 |
GO:0010763 |
Process |
Positive regulation of fibroblast migration |
IEA |
|
GO:0010765 |
Process |
Positive regulation of sodium ion transport |
IEA |
|
GO:0010907 |
Process |
Positive regulation of glucose metabolic process |
IMP |
16814735 |
GO:0010918 |
Process |
Positive regulation of mitochondrial membrane potential |
IMP |
10983986 |
GO:0010951 |
Process |
Negative regulation of endopeptidase activity |
IMP |
18387192 |
GO:0010975 |
Process |
Regulation of neuron projection development |
ISS |
|
GO:0014065 |
Process |
Phosphatidylinositol 3-kinase signaling |
IMP |
26514923 |
GO:0015630 |
Component |
Microtubule cytoskeleton |
IDA |
|
GO:0016242 |
Process |
Negative regulation of macroautophagy |
NAS |
23778976 |
GO:0016301 |
Function |
Kinase activity |
IDA |
14749367 |
GO:0016310 |
Process |
Phosphorylation |
IDA |
20333297 |
GO:0016567 |
Process |
Protein ubiquitination |
IEA |
|
GO:0018105 |
Process |
Peptidyl-serine phosphorylation |
IBA |
21873635 |
GO:0018105 |
Process |
Peptidyl-serine phosphorylation |
IDA |
16139227, 32322062 |
GO:0018105 |
Process |
Peptidyl-serine phosphorylation |
TAS |
21711983 |
GO:0018107 |
Process |
Peptidyl-threonine phosphorylation |
IDA |
20605787 |
GO:0019221 |
Process |
Cytokine-mediated signaling pathway |
TAS |
|
GO:0019899 |
Function |
Enzyme binding |
ISS |
|
GO:0021510 |
Process |
Spinal cord development |
IEA |
|
GO:0030027 |
Component |
Lamellipodium |
NAS |
19126672 |
GO:0030030 |
Process |
Cell projection organization |
IEA |
|
GO:0030154 |
Process |
Cell differentiation |
TAS |
21432781 |
GO:0030163 |
Process |
Protein catabolic process |
IEA |
|
GO:0030212 |
Process |
Hyaluronan metabolic process |
IEA |
|
GO:0030235 |
Function |
Nitric-oxide synthase regulator activity |
IMP |
10376603 |
GO:0030307 |
Process |
Positive regulation of cell growth |
IDA |
19203586 |
GO:0030334 |
Process |
Regulation of cell migration |
IMP |
19934221 |
GO:0030334 |
Process |
Regulation of cell migration |
TAS |
21432781 |
GO:0031018 |
Process |
Endocrine pancreas development |
TAS |
|
GO:0031234 |
Component |
Extrinsic component of cytoplasmic side of plasma membrane |
NAS |
19126672 |
GO:0031295 |
Process |
T cell costimulation |
TAS |
|
GO:0031397 |
Process |
Negative regulation of protein ubiquitination |
IMP |
18292230 |
GO:0031641 |
Process |
Regulation of myelination |
IEA |
|
GO:0031663 |
Process |
Lipopolysaccharide-mediated signaling pathway |
IEA |
|
GO:0031929 |
Process |
TOR signaling |
NAS |
23778976 |
GO:0031982 |
Component |
Vesicle |
IDA |
16792529 |
GO:0031999 |
Process |
Negative regulation of fatty acid beta-oxidation |
IMP |
16814735 |
GO:0032079 |
Process |
Positive regulation of endodeoxyribonuclease activity |
IDA |
20605787 |
GO:0032091 |
Process |
Negative regulation of protein binding |
IMP |
18292230 |
GO:0032094 |
Process |
Response to food |
IEA |
|
GO:0032148 |
Process |
Activation of protein kinase B activity |
TAS |
|
GO:0032270 |
Process |
Positive regulation of cellular protein metabolic process |
ISS |
|
GO:0032287 |
Process |
Peripheral nervous system myelin maintenance |
IEA |
|
GO:0032436 |
Process |
Positive regulation of proteasomal ubiquitin-dependent protein catabolic process |
IEA |
|
GO:0032794 |
Function |
GTPase activating protein binding |
IEA |
|
GO:0032869 |
Process |
Cellular response to insulin stimulus |
IMP |
16814735 |
GO:0032869 |
Process |
Cellular response to insulin stimulus |
ISS |
|
GO:0032991 |
Component |
Protein-containing complex |
IDA |
10983986, 20878056 |
GO:0033138 |
Process |
Positive regulation of peptidyl-serine phosphorylation |
IDA |
19667065 |
GO:0034405 |
Process |
Response to fluid shear stress |
IMP |
10376603 |
GO:0034614 |
Process |
Cellular response to reactive oxygen species |
IMP |
26514923 |
GO:0035556 |
Process |
Intracellular signal transduction |
IBA |
21873635 |
GO:0035556 |
Process |
Intracellular signal transduction |
IDA |
14749367 |
GO:0035655 |
Process |
Interleukin-18-mediated signaling pathway |
IDA |
21321938 |
GO:0035924 |
Process |
Cellular response to vascular endothelial growth factor stimulus |
IEA |
|
GO:0036064 |
Component |
Ciliary basal body |
IEA |
|
GO:0038061 |
Process |
NIK/NF-kappaB signaling |
IMP |
26514923 |
GO:0042593 |
Process |
Glucose homeostasis |
IEA |
|
GO:0042802 |
Function |
Identical protein binding |
IPI |
7891724, 17554339 |
GO:0042803 |
Function |
Protein homodimerization activity |
IDA |
10983986 |
GO:0042981 |
Process |
Regulation of apoptotic process |
ISS |
|
GO:0043065 |
Process |
Positive regulation of apoptotic process |
IEA |
|
GO:0043066 |
Process |
Negative regulation of apoptotic process |
IDA |
19203586 |
GO:0043066 |
Process |
Negative regulation of apoptotic process |
IMP |
10983986 |
GO:0043154 |
Process |
Negative regulation of cysteine-type endopeptidase activity involved in apoptotic process |
ISS |
|
GO:0043276 |
Process |
Anoikis |
NAS |
23778976 |
GO:0043325 |
Function |
Phosphatidylinositol-3,4-bisphosphate binding |
IDA |
19203586 |
GO:0043488 |
Process |
Regulation of mRNA stability |
TAS |
|
GO:0043491 |
Process |
Protein kinase B signaling |
IMP |
28341552 |
GO:0043491 |
Process |
Protein kinase B signaling |
TAS |
|
GO:0043536 |
Process |
Positive regulation of blood vessel endothelial cell migration |
IDA |
20011604 |
GO:0045429 |
Process |
Positive regulation of nitric oxide biosynthetic process |
IMP |
10376603 |
GO:0045600 |
Process |
Positive regulation of fat cell differentiation |
IMP |
8940145 |
GO:0045725 |
Process |
Positive regulation of glycogen biosynthetic process |
IMP |
16814735 |
GO:0045725 |
Process |
Positive regulation of glycogen biosynthetic process |
NAS |
17925406 |
GO:0045737 |
Process |
Positive regulation of cyclin-dependent protein serine/threonine kinase activity |
IMP |
18483258 |
GO:0045742 |
Process |
Positive regulation of epidermal growth factor receptor signaling pathway |
TAS |
|
GO:0045746 |
Process |
Negative regulation of Notch signaling pathway |
TAS |
|
GO:0045792 |
Process |
Negative regulation of cell size |
IEA |
|
GO:0045861 |
Process |
Negative regulation of proteolysis |
IMP |
18387192 |
GO:0045893 |
Process |
Positive regulation of transcription, DNA-templated |
IMP |
26514923 |
GO:0045907 |
Process |
Positive regulation of vasoconstriction |
IEA |
|
GO:0045944 |
Process |
Positive regulation of transcription by RNA polymerase II |
IEA |
|
GO:0046326 |
Process |
Positive regulation of glucose import |
IMP |
8940145, 16814735 |
GO:0046329 |
Process |
Negative regulation of JNK cascade |
IEA |
|
GO:0046622 |
Process |
Positive regulation of organ growth |
IEA |
|
GO:0046777 |
Process |
Protein autophosphorylation |
TAS |
16280327 |
GO:0046889 |
Process |
Positive regulation of lipid biosynthetic process |
IDA |
32322062 |
GO:0046889 |
Process |
Positive regulation of lipid biosynthetic process |
IMP |
8940145 |
GO:0048009 |
Process |
Insulin-like growth factor receptor signaling pathway |
IMP |
8978681 |
GO:0048661 |
Process |
Positive regulation of smooth muscle cell proliferation |
IDA |
21321938 |
GO:0050999 |
Process |
Regulation of nitric-oxide synthase activity |
TAS |
|
GO:0051000 |
Process |
Positive regulation of nitric-oxide synthase activity |
IMP |
10376603 |
GO:0051091 |
Process |
Positive regulation of DNA-binding transcription factor activity |
IDA |
19057511 |
GO:0051146 |
Process |
Striated muscle cell differentiation |
IEA |
|
GO:0051721 |
Function |
Protein phosphatase 2A binding |
IEA |
|
GO:0051898 |
Process |
Negative regulation of protein kinase B signaling |
TAS |
|
GO:0060079 |
Process |
Excitatory postsynaptic potential |
NAS |
21711983 |
GO:0060416 |
Process |
Response to growth hormone |
ISS |
|
GO:0060644 |
Process |
Mammary gland epithelial cell differentiation |
TAS |
21432781 |
GO:0060716 |
Process |
Labyrinthine layer blood vessel development |
IEA |
|
GO:0070141 |
Process |
Response to UV-A |
IDA |
18483258 |
GO:0071260 |
Process |
Cellular response to mechanical stimulus |
IEA |
|
GO:0071276 |
Process |
Cellular response to cadmium ion |
IMP |
26514923 |
GO:0071356 |
Process |
Cellular response to tumor necrosis factor |
IMP |
10983986 |
GO:0071364 |
Process |
Cellular response to epidermal growth factor stimulus |
IEA |
|
GO:0071380 |
Process |
Cellular response to prostaglandin E stimulus |
IEA |
|
GO:0071407 |
Process |
Cellular response to organic cyclic compound |
IEA |
|
GO:0071456 |
Process |
Cellular response to hypoxia |
IEA |
|
GO:0071889 |
Function |
14-3-3 protein binding |
IPI |
10102273 |
GO:0071901 |
Process |
Negative regulation of protein serine/threonine kinase activity |
TAS |
28386764 |
GO:0072655 |
Process |
Establishment of protein localization to mitochondrion |
IMP |
23962723 |
GO:0072656 |
Process |
Maintenance of protein location in mitochondrion |
IMP |
23962723 |
GO:0090201 |
Process |
Negative regulation of release of cytochrome c from mitochondria |
ISS |
|
GO:0097011 |
Process |
Cellular response to granulocyte macrophage colony-stimulating factor stimulus |
IEA |
|
GO:0097194 |
Process |
Execution phase of apoptosis |
IEA |
|
GO:0098794 |
Component |
Postsynapse |
IEA |
|
GO:0100002 |
Process |
Negative regulation of protein kinase activity by protein phosphorylation |
TAS |
21711983 |
GO:0106310 |
Function |
Protein serine kinase activity |
IEA |
|
GO:0106311 |
Function |
Protein threonine kinase activity |
IEA |
|
GO:0140052 |
Process |
Cellular response to oxidised low-density lipoprotein particle stimulus |
IMP |
28341552 |
GO:1900087 |
Process |
Positive regulation of G1/S transition of mitotic cell cycle |
IMP |
18483258 |
GO:1900182 |
Process |
Positive regulation of protein localization to nucleus |
IMP |
20605787 |
GO:1901215 |
Process |
Negative regulation of neuron death |
NAS |
18221368 |
GO:1901796 |
Process |
Regulation of signal transduction by p53 class mediator |
TAS |
|
GO:1902176 |
Process |
Negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway |
NAS |
16604263 |
GO:1903038 |
Process |
Negative regulation of leukocyte cell-cell adhesion |
IMP |
28341552 |
GO:1903078 |
Process |
Positive regulation of protein localization to plasma membrane |
IMP |
8940145 |
GO:1903721 |
Process |
Positive regulation of I-kappaB phosphorylation |
IMP |
26514923 |
GO:1990090 |
Process |
Cellular response to nerve growth factor stimulus |
IMP |
20605787 |
GO:1990418 |
Process |
Response to insulin-like growth factor stimulus |
ISS |
|
GO:2000010 |
Process |
Positive regulation of protein localization to cell surface |
IEA |
|
GO:2000402 |
Process |
Negative regulation of lymphocyte migration |
IMP |
28341552 |
GO:2001240 |
Process |
Negative regulation of extrinsic apoptotic signaling pathway in absence of ligand |
TAS |
10748004 |
|
Other IDsOther ids provides unique ids of gene in databases such as OMIM, HGNC, ENSEMBLE.
|
|
Protein
|
UniProt ID |
P31749 |
Protein name |
RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha) |
Protein function |
AKT1 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis (PubMed:15526160, PubMed:11882383, PubMed:21620960, PubMed:21432781). This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates (PubMed:15526160, PubMed:11882383, PubMed:21620960, PubMed:21432781). Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported (PubMed:15526160, PubMed:11882383, PubMed:21620960, PubMed:21432781). AKT is responsible of the regulation of glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface (By similarity). Phosphorylation of PTPN1 at 'Ser-50' negatively modulates its phosphatase activity preventing dephosphorylation of the insulin receptor and the attenuation of insulin signaling (By similarity). Phosphorylation of TBC1D4 triggers the binding of this effector to inhibitory 14-3-3 proteins, which is required for insulin-stimulated glucose transport (PubMed:11994271). AKT regulates also the storage of glucose in the form of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at 'Ser-9', resulting in inhibition of its kinase activity (By similarity). Phosphorylation of GSK3 isoforms by AKT is also thought to be one mechanism by which cell proliferation is driven (By similarity). AKT regulates also cell survival via the phosphorylation of MAP3K5 (apoptosis signal-related kinase) (PubMed:11154276). Phosphorylation of 'Ser-83' decreases MAP3K5 kinase activity stimulated by oxidative stress and thereby prevents apoptosis (PubMed:11154276). AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462', thereby activating mTORC1 signaling and leading to both phosphorylation of 4E-BP1 and in activation of RPS6KB1 (PubMed:12150915). AKT is involved in the phosphorylation of members of the FOXO factors (Forkhead family of transcription factors), leading to binding of 14-3-3 proteins and cytoplasmic localization (PubMed:10358075). In particular, FOXO1 is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319' (PubMed:10358075). FOXO3 and FOXO4 are phosphorylated on equivalent sites (PubMed:10358075). AKT has an important role in the regulation of NF-kappa-B-dependent gene transcription and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-response element binding protein) (PubMed:9829964). The phosphorylation of CREB1 induces the binding of accessory proteins that are necessary for the transcription of pro-survival genes such as BCL2 and MCL1 (PubMed:9829964). AKT phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby potentially regulating ACLY activity and fatty acid synthesis (By similarity). Activates the 3B isoform of cyclic nucleotide phosphodiesterase (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced cyclic AMP levels and inhibition of lipolysis (By similarity). Phosphorylates PIKFYVE on 'Ser-318', which results in increased PI(3)P-5 activity (By similarity). The Rho GTPase-activating protein DLC1 is another substrate and its phosphorylation is implicated in the regulation cell proliferation and cell growth. AKT plays a role as key modulator of the AKT-mTOR signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation (By similarity). Signals downstream of phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin and insulin-like growth factor I (IGF-I) (PubMed:12176338, PubMed:12964941). AKT mediates the antiapoptotic effects of IGF-I (By similarity). Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly (PubMed:19934221). May be involved in the regulation of the placental development (By similarity). Phosphorylates STK4/MST1 at 'Thr-120' and 'Thr-387' leading to inhibition of its: kinase activity, nuclear translocation, autophosphorylation and ability to phosphorylate FOXO3 (PubMed:17726016). Phosphorylates STK3/MST2 at 'Thr-117' and 'Thr-384' leading to inhibition of its: cleavage, kinase activity, autophosphorylation at Thr-180, binding to RASSF1 and nuclear translocation (PubMed:20086174, PubMed:20231902). Phosphorylates SRPK2 and enhances its kinase activity towards SRSF2 and ACIN1 and promotes its nuclear translocation (PubMed:19592491). Phosphorylates RAF1 at 'Ser-259' and negatively regulates its activity (PubMed:10576742). Phosphorylation of BAD stimulates its pro-apoptotic activity (PubMed:10926925). Phosphorylates KAT6A at 'Thr-369' and this phosphorylation inhibits the interaction of KAT6A with PML and negatively regulates its acetylation activity towards p53/TP53 (PubMed:23431171). Phosphorylates palladin (PALLD), modulating cytoskeletal organization and cell motility (PubMed:20471940). Phosphorylates prohibitin (PHB), playing an important role in cell metabolism and proliferation (PubMed:18507042). Phosphorylates CDKN1A, for which phosphorylation at 'Thr-145' induces its release from CDK2 and cytoplasmic relocalization (PubMed:16982699). These recent findings indicate that the AKT1 isoform has a more specific role in cell motility and proliferation (PubMed:16139227). Phosphorylates CLK2 thereby controlling cell survival to ionizing radiation (PubMed:20682768). Phosphorylates PCK1 at 'Ser-90', reducing the binding affinity of PCK1 to oxaloacetate and changing PCK1 into an atypical protein kinase activity using GTP as donor (PubMed:32322062). Also acts as an activator of TMEM175 potassium channel activity in response to growth factors: forms the lysoK(GF) complex together with TMEM175 and acts by promoting TMEM175 channel activation, independently of its protein kinase activity (PubMed:32228865). |
PDB |
1H10
,
1UNP
,
1UNQ
,
1UNR
,
2UVM
,
2UZR
,
2UZS
,
3CQU
,
3CQW
,
3MV5
,
3MVH
,
3O96
,
3OCB
,
3OW4
,
3QKK
,
3QKL
,
3QKM
,
4EJN
,
4EKK
,
4EKL
,
4GV1
,
5KCV
,
6BUU
,
6CCY
,
6HHF
,
6HHG
,
6HHH
,
6HHI
,
6HHJ
,
6NPZ
,
6S9W
,
6S9X
|
Family and domains |
Pfam
Accession |
ID |
Position in sequence |
Description |
Type |
PF00169 |
PH |
6 → 108 |
PH domain |
Domain |
PF00069 |
Pkinase |
150 → 408 |
Protein kinase domain |
Domain |
PF00433 |
Pkinase_C |
429 → 474 |
Protein kinase C terminal domain |
Family |
|
Sequence |
|
Sequence length |
480 |
Interactions |
View interactions |
|
|